Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2900001000001114 | Generic Epimax eyelid ointment preservative free 4 gram | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2900021000001119 | Generic Epimax eyelid ointment preservative free 4 gram (physical object) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Generic Epimax eyelid ointment preservative free 4 gram | Is a | Virtual appliance pack | true | Inferred relationship | Existential restriction modifier | ||
| Generic Epimax eyelid ointment preservative free 4 gram | Has VMP | Generic Epimax eyelid ointment preservative free | true | Inferred relationship | Existential restriction modifier | ||
| Generic Epimax eyelid ointment preservative free 4 gram | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Generic Epimax eyelid ointment preservative free 4 gram | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Generic Epimax eyelid ointment preservative free 4 gram | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Epimax eyelid ointment preservative free (Aspire Pharma Ltd) 4 gram | Is a | True | Generic Epimax eyelid ointment preservative free 4 gram | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR